In this Webinar of May Awareness Month, Vissia Viglietta will be speaking on behalf of Wave Life Sciences. She would explain the results and all the good work they have been doing in improving from the updated on PRECISION-HD1 and PRECISION-HD2 medical trials. Wave would also present the promising approach that they are pursuing, the WVE-003 Project.
The WVE-003 Project
Wave is developing a third allele-selective HD candidate, WVE-003, which is designed to selectively target an undisclosed SNP on the mHTT mRNA transcript (SNP3), while leaving wtHTT protein relatively intact. In other words, Wave has the potential to provide allele-selective options for up to 80% of people with HD.
Speaker: Vissia Viglietta
Vice President Global Clinical Development and Medical Affairs at Wave Life Sciences
WHEN: 12. May, 19:00-20:30 Central European Time
PLATFORM: Zoom
Link here to register: https://bit.ly/3xp2ay2
The European Academy of Neurology (EAN) is hosting their 7th Congress in June 2021. This years theme: Towards Precision Neurology.
From Claudio L. Bassetti, EAN President:
“As the number of lives affected by the COVID-19 pandemic has now reached the millions, the health and safety of our congress attendees, our patients and our families, remains our primary concern.
While we may come from different nations, we are all experiencing difficult and trying times, and we must continue to work together to slow the spread of the disease.
With this situation in mind, the European Academy of Neurology has decided to go virtual again for the 7th EAN Congress on June 19-22, 2021, originally to be held in Vienna.
Once again, we look forward to offering you the opportunity to learn from experts in your field, grow your professional network, and discover the latest best practices in neurology, all in the comfort of your home. Building on our experience from the EAN Virtual Congress 2020, we will utilise the very best technical solutions to provide you with a virtual experience as comfortable and rewarding as the real thing.
In order to make participation affordable for colleagues all over the world, EAN is offering reduced fees for the virtual congress.
Please find detailed information on the EAN Congress Website.”
Registration is now open!
Cost per ticket depends on whether you are a EAN member or not and your membership (student, researcher, etc.).
Every second year European Huntington’s Disease Network (EHDN) hosts one of the world’s largest conferences dedicated solely to Huntington’s disease (HD). In 2021, the EHDN Plenary Meeting will take place in Bologna, Italy September 10-12.
The Plenary Meeting is open to clinicians, scientists, EHA delegates and members of families affected by Huntington’s disease (HD). You can learn more about recent advances in research and attendees have the opportunity to meet people in the field of HD studies in more informal settings.
Usually, EHDN members are entitled to have their travel and accommodation costs reimbursed up to a maximum of 400 EUR for travels within Europe and 600 EUR for travels from non-European countries. Costs above these amounts cannot be covered by the EHDN. Reimbursement forms need to be submitted after the Plenary Meeting.
Timelines
Abstract submission: May – June 2021
Registration: May – July 2021
More details will follow.